1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
44.99%
R&D growth above 1.5x CRVO's 5.59%. Michael Burry would check for spending discipline.
-4.08%
G&A reduction while CRVO shows 37.03% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
80.19%
Similar other expenses growth to CRVO's 100.00%. Walter Schloss would investigate industry patterns.
21.99%
Operating expenses growth less than half of CRVO's 251.41%. David Dodd would verify sustainability.
21.99%
Total costs growth 1.25-1.5x CRVO's 15.98%. Martin Whitman would scrutinize control.
No Data
No Data available this quarter, please select a different quarter.
80.19%
D&A growth while CRVO reduces D&A. John Neff would investigate differences.
32.89%
EBITDA growth while CRVO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
-21.99%
Both companies show declining income. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
198.65%
Other expenses growth while CRVO reduces costs. John Neff would investigate differences.
32.68%
Pre-tax income growth while CRVO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32.68%
Net income growth while CRVO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
32.51%
EPS growth while CRVO declines. John Neff would investigate advantages.
32.51%
Diluted EPS growth while CRVO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.